Fraser, W., Hosking, D., Miller, P., Brown, J., Lyles, K., Moniz, C., … Reid, I. (2004). Zoledronic acid produces greater and faster efficacy versus risedronate in patients with Paget's disease. In OSTEOPOROSIS INTERNATIONAL (Vol. 15, pp. S35–S35). Harrogate, ENGLAND: SPRINGER LONDON LTD.

Fraser, W., D. Hosking, P. Miller, J. Brown, K. Lyles, C. Moniz, M. Diaz-Curiel, et al. “Zoledronic acid produces greater and faster efficacy versus risedronate in patients with Paget's disease.” In OSTEOPOROSIS INTERNATIONAL, 15:S35–S35. SPRINGER LONDON LTD, 2004.

Fraser W, Hosking D, Miller P, Brown J, Lyles K, Moniz C, et al. Zoledronic acid produces greater and faster efficacy versus risedronate in patients with Paget's disease. In: OSTEOPOROSIS INTERNATIONAL. SPRINGER LONDON LTD; 2004. p. S35–S35.

Fraser, W., et al. “Zoledronic acid produces greater and faster efficacy versus risedronate in patients with Paget's disease.” OSTEOPOROSIS INTERNATIONAL, vol. 15, SPRINGER LONDON LTD, 2004, pp. S35–S35.

Fraser W, Hosking D, Miller P, Brown J, Lyles K, Moniz C, Diaz-Curiel M, Hunt P, Levitt NS, Pak J, Su G, Luchi M, Zelenakas K, Saidi Y, Reid I. Zoledronic acid produces greater and faster efficacy versus risedronate in patients with Paget's disease. OSTEOPOROSIS INTERNATIONAL. SPRINGER LONDON LTD; 2004. p. S35–S35.